Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is an effective and safe treatment for alopecia areata.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Vitamin A affects hair loss and immune response in alopecia areata.

RANKL causes lymph nodes to grow by making certain cells multiply.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Low BMI and cold exposure increase the risk of chilblains.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

WNT signaling is crucial for skin development and healing.

New treatments for hair loss are emerging, and doctors need to learn how to use them effectively.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

People with alopecia areata in German-speaking countries spend a lot on their condition, with hair products and treatments being the most costly.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Early recognition and treatment of SLE can improve outcomes in patients with complex symptoms.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

CBD is effective for certain epilepsy conditions, shows promise for other health issues, but needs more research for safety and effectiveness.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.